Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany.

Reinisch, Mattea; Bruzas, Simona; Spoenlein, Jennifer; Shenoy, Satyendra; Traut, Alexander; Harrach, Hakima; Chiari, Ouafaa; Cremer, Efsthatia; Ataseven, Beyhan; Gubelt, Lars; Kuemmel, Sherko

Reinisch, Mattea; Bruzas, Simona; Spoenlein, Jennifer; Shenoy, Satyendra; Traut, Alexander; Harrach, Hakima; Chiari, Ouafaa; Cremer, Efsthatia; Ataseven, Beyhan; Gubelt, Lars; Kuemmel, Sherko.

Afiliação

Reinisch M; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Henricistrasse 92, Essen 45136, Germany.
Bruzas S; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
Spoenlein J; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
Shenoy S; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
Traut A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Harrach H; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
Chiari O; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
Cremer E; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
Ataseven B; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Gubelt L; Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-Universität, Munich, Germany.
Kuemmel S; Zentralapotheke, Kliniken Essen-Mitte, Essen, Germany.